Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NES-E2 CVR for Female Contraception
NCT03432416Phase 2Completed
- Sponsor
- Premier Research
- Start
- Feb 2018
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of segesterone and estradiol in contraception (2 arms), sponsored by Premier Research. Primary endpoint: Pregnancy Rate at 1 year. Started Feb 2018; status: completed.
02
Drugs
segesteroneestradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03432416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432416.